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INTRODUCTION
G laucoma currently represents a leading cause of irreversible vision loss worldwide. Although the progression can be slowed or halted by hypotensive therapy via medical, surgical or laser treatments, some patients in clinical practice who fall within the normal range of intraocular pressure (IOP) still suffer from progressive visual function loss [1] . Therefore, besides measuring the IOP, researchers have commenced looking for independent risk factors for glaucoma progression. Potential risk factors as IOP fluctuation, myopia, age, blood pressure and family history have come into researchers' sight [2] . To date, great quantity of studies on such topics have been published, especially in IOP fluctuation, including two of the large well known glaucoma clinical studies: Advanced Glaucoma Intervention Study (AGIS) [3] and Early Manifest Glaucoma Trial (EMGT) [4] . Nevertheless, the coincidence of IOP fluctuation and glaucoma progression had not been concluded within these published studies. For instance, AGIS reported that IOP fluctuation was a risk factor for glaucoma progression [3] , while EMGT concluded that IOP fluctuation was not a factor for glaucoma development and progression [4] . Besides, the majority of publications mentioned above which relevant to IOP fluctuation and glaucoma were designed as large longitudinal studies with a long follow-up duration. During such long follow-up period, it is prone to result in censored data from lost to follow-up, death, or other situations. Thus, for these types of data with subsets of inevitable censored data, it has been advocated to be analyzed with Cox proportional hazards model [5] and consider hazard ratio (HR)
as combined effect estimate in the Meta-analysis of survival data [6] . Hence, we objected to conduct the Meta-analysis based on time-to-event data with respect of the conflict relationship between IOP fluctuation and glaucoma onset or progression. All retrieved items were imported into EndNote X7, and those duplicate reports were manually removed. There was no limitation of language. Included papers were shown in the reference, and were further reviewed to identify the potential eligibility.
MATERIALS AND METHODS

Inclusion and Exclusion Criteria
The studies were included if they met the following criteria: 1) patients were openangle glaucoma (OAG) or suspects; 2) IOP fluctuation as the covariant; 3) visual field or relative glaucomatous structure parameters progression as end point; 4) reported HR estimates with 95% confidence intervals (CIs) from Cox proportional hazards model or allowed to calculate these statistics according to presented data and survival curves [7] [8] . IOP fluctuation, a time-dependent variable, was classified into short-term or long-term fluctuation. The short-term fluctuation referred to fluctuation within a time period that was less than or equal to 24h, while the long-term fluctuation was defined as fluctuation within a time period longer than 24h [9] . The long-term fluctuation could be calculated either as the difference between the highest and the lowest IOP values or the standard deviation (SD) of all IOP readings. If the same study population was presented in multiple publications, only the one which the methodology was more homologous to others would be further analyzed to avoid possible bias [10] .
Data Extraction and Quality Assessment
The following characteristics of each included studies were extracted: first author's last name, publication year, study design, sample type and size, age, follow-up duration, sex distribution, ethnicity of the study population, type of tonometer and perimetry, definition of IOP fluctuation and glaucoma progression, and adjustment risk factors. Although one of the included reports was published as an abstract in the Association for Research in Vision and Ophthalmology (ARVO) annual meeting [11] , its data and the segmental information were completely derived from the AGIS [12] . To compute the combined HR estimates with 95%CIs, data including the natural logarithm HR and standard error (SE) were necessary. Most HR and 95%CIs were reported in the majority of articles that the required data could be easily generated. Only one [11] of the studies provided HR and P value, hence the SE value was calculated with formula (logarithm of HR/Z statistic corresponding to P value). There were no validated or established tools for estimating the observational studies quality [13] . Therefore, we examined and compared the included reports with following items: methods for measuring and calculating IOP fluctuation and glaucoma progression, design-specific sources of bias, methods for controlling confounding, statistical methods, and conflict of interest (COI) [14] . All included reports had no COI and were further presented in Tables 1 and 2 . Statistical Analysis Summary effect estimate was calculated with the method of inverse variance. Statistical heterogeneity among studies was examined by the Q test (P<0.1 was considered as statistically significant) and measured with I 2 statistic, which was the proportion of between-study variation in total variation [15] . If I 2 was no more than 50%, we used fixed effects model to calculate the pooled HR and 95%CIs. Otherwise the combined effect estimate was calculated with random effects model [16] , which not only weighed the study based on sample size, but also based on between-study variation (such as inclusion criteria of cases, age and sex distribution of study populations, and differences in follow-up time) to compensate for the heterogeneity. Sensitivity analysis was conducted to investigate the potential influence on the pooled HR estimate by omitting one or more studies and combining the remainders. Differences between the subgroups were estimated via comparing the combined effect estimates with Chi-square analysis. Potential publication bias was rated by funnel plots. All analyses were run using Review Manager (Version 5.3 Cochrane Collaboration, Nordic Cochrane Centre, Copenhagen, Denmark). A two-tailed P value less than 0.05 was considered statistically significant. RESULTS Fifteen literatures [4, 11, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , published from 1998 to 2016, met the inclusion criteria as the flow diagram of screening eligible studies shown (Figure 1 ). Nevertheless, one study [25] in line with the prespecified rules was excluded on account of the [23] study. Therefore, the overview information of final 14 eligible studies were shown as Table 1 . All qualified studies referred to 2211 eyes of 2637 OAG patients, except the study with an unavailable study size [26] . These included publications were composed of 2 abstracts from the ARVO annual meeting and 12 full-text articles. Different types of IOP fluctuation reported by all included studies were specified as 4 reports on short-term IOP fluctuation (difference of the nadir and peak IOP within 24h) and 10 studies about the long-term IOP fluctuation (SD of all included IOP readings). Two reports among the 14 included studies were respectively with two study subgroups, consequently 16 data items (Table 2) were for further Meta-analysis. Among these, eight raw data items were identified that the IOP fluctuation was a statistically significant risk factor for glaucoma progression, and the other eight remainders did not. The pooled HR was 1.23 (95%CI 1.04-1.46, P=0.02), which was computed by random effect model due to statistical heterogeneity (P<0.1).
According to different types of IOP fluctuation within eligible publications, stratification analysis was performed between Sensitivity analysis showed that the heterogeneity among the group with regard to long-term IOP fluctuation was mainly contributed by the following three studies (Figure 2 ). These studies were roughly homogeneous with others, except one study was designed as a cohort study [21] , another study collected IOP readings by patients using home tonometry measurements [18] , and the other study considered the change of Heidelberg Retina Tomography (HRT) as a glaucoma progression criterion [26] . When omitting these studies, the combined HR was 1. [30] . LC is composed of capillaries, astrocytes, fibrocytes and extracellular 
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Int J Ophthalmol, Vol. 12, No. 1, Jan.18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com matrix (ECM), which principally contains various collagens, elastins, and proteoglycans. The LC is endowed biomechanical properties with ECM and has been as an IOP-related stress load-bearing tissue [31] . IOP fluctuation relevant to mechanical stress within the sieve pores could be magnified 122 times by the three dimensional geometry detailed as the overlapped lamellar connective tissues in the scleral canal of spherical ocular shell [32] . A long-term oscillation of mechanical stress can enhance fatiguing effects on collagens and elastins. Once the shear, tensile and compressive stress is beyond loadinglimits of fibroelastic tissues, it can cause hypercompliance and permanent deformation to tissues [31] . Meanwhile, the applied stress may activate gliocytes to trigger relevant downstream signaling pathways and result in structural modification of the LC. Proliferative ECM not only makes LC stiffer, but also decreases the efficiency of nutrients delivery from capillaries in LC [33] . Although it's difficult to explore the exact way of how IOP fluctuation damage on glaucoma from the IOP effect in vivo, according to the established proof above, we can conclude that IOP fluctuation may related to stress effect on LC and its capillaries to further cause injury of retinal ganglion cells (RGCs). In this Meta-analysis, all included literatures were longitudinal studies with the longest mean follow-up period up to 8.5y. When progressed cases occurred during the follow-up time, the intensified treatment regimen was required for lowering the IOP of patients. Once changing the therapeutic schedule, it must lead to alteration of IOP fluctuation outcome. One study in our analysis, which data were derived from the AGIS, calculated IOP fluctuation including the IOP dataset after changing the therapeutic schedule [11] . This may result in a consequent increase of IOP fluctuation and can lead to a non-naturally positive association between IOP fluctuation and glaucoma progression in the AGIS. When the report of AGIS was removed from our analysis, the combined result 1.28 (95%CI 1.04-1.59, P=0.02) was still statistically significant with a slight increase of heterogeneity compared to our previous pooled result (P<0.1). However, the reason of deleting one different calculation of IOP fluctuation from included studies increased the heterogeneity remains unclear.
The overall HR was statistically significant with heterogeneity among all observational studies in this Meta-analysis. The present heterogeneity can be interpreted as following aspects.
Firstly, the Meta-analysis of observational studies usually is confronted with challenges due to different study designs.
Excluding sole cohort study from included studies make heterogeneity (I 2 statistic) decline from 81% to 58%. Secondly, glaucoma deterioration. Thus, it should also be followed in clinic to protect the vision functions of glaucoma patients.
